Past CureTalks
Living Well with Prostate Cancer
Quality of life is a major concern of patients when they are choosing treatment for prostate cancer. Our prostate cancer panel led by Mike Scott is talking to Dr. Paul Schellhammer, a prostate cancer survivor himself, about treatment outcomes and…
Immunotherapy Advances in Multiple Myeloma
Recent years have seen the emergence of immunotherapy as a leading form of treatment for multiple myeloma. New strategies such as monoclonal antibody therapies. antibody-drug conjugates, immune checkpoint therapy, adoptive cell therapies such as natural killer cells, marrow infiltrating lymphocytes,…
Developments in Personalized Medicine and New Options in Breast Cancer Treatment
In this era of personalized medicine the standard "one dose fits all" approach to cancer care has been ineffective leading to treatment failures. Personalized medicine is a new healthcare paradigm that allows physicians to choose treatment methodology optimally based on…
Nonsecretory Multiple Myeloma: New Options in Assessment and Treatment
Hallmark of most multiple myeloma cases is the persistent production of some form of immunoglobulins, a phenomenon that brings the disease to attention. However, there is a subset of multiple myeloma patients who do not secrete immunoglobulin or its component…
High Risk Myeloma Treatment Options
Myeloma is classified as high-risk based on presence of cytogenetic abnormalities and poor treatment outcomes. Despite many new drugs and drug combinations being approved, long term benefits for high risk multiple myeloma patients is less clear. We continue our discussion…